RHABDOMYOLYSIS DUE TO Escherichia coli SEPSIS IN THREE PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

REFERENCES

• Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006; 118: 2119–2125
   PubMed Web of Science ®Google Scholar
• Martino R, Santamaria A, Pericas R, Sureda A, Brunet S. Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases. Haematologica. 1997; 82: 692–624
   PubMedGoogle Scholar
• Tomiyama J, Hasegawa Y, Nagasawa T, Abe T, Horiguchi H, Ogata T. Bacillus cereus septicemia associated with rhabdomyolysis and myoglobinuric renal failure. Jpn J Med. 1989; 28: 247–250
   PubMedGoogle Scholar
• Funada H, Shirasaki H, Matsuda T, Akasofu M. Rhabdomyolysis complicating polymicrobial sepsis in a patient with acute leukemia. Intern Med. 1996; 35: 36–38
   Google Scholar
• Sandlund JT, Howard SC, Hijiya N, Pui CH, Shenep JL, Adderson EE. Myositis complicating viridans streptococcal sepsis in childhood leukemia. Pediatr Blood Cancer. 2005; 44: 277–279
   Google Scholar
• Sigurdardottir K, Digranes A, Harthug S, et al. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility. Scand J Infect Dis 2005; 37: 455–464
   PubMed Web of Science ®Google Scholar
• Paul M, Gafter-Gvili A, Leibovici L, et al. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988–2004. Isr Med Assoc J. 2007; 9: 424–429
   PubMed Web of Science ®Google Scholar
• Arnello L M, Quintana B JA, Barraza C P. Febrile neutropenia in children with cancer in a medical center of Santiago, Chile. Rev Chilena Infectol. 2007; 24: 27–32
   Google Scholar
• Figuera Esparza M, Carballo M, Silva M, Figueredo A, Avilan J. Microbiological isolates in patients with febrile neutropenia and hematological neoplasias. Rev Esp Quimioter. 2006; 19: 247–251
   Google Scholar
• Tezcan G, Kupesiz A, Ozturk F, et al. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey. Pediatr Hematol Oncol. 2006; 23: 217–229
   PubMed Web of Science ®Google Scholar
• Betrosian A, Thireos E, Kofinas G, Balla M, Papanikolaou M, Georgiadis G. Bacterial sepsis-induced rhabdomyolysis. Intensive Care Med. 1999; 25: 469–474
   PubMed Web of Science ®Google Scholar
• Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM. Childhood and adolescent lymphoid and myeloid leukemia. Hematol Am Soc Hematol Educ Program. 2004; 118–145
   Google Scholar
• Christensen MS, Heyman M, Mottonen M, Zeller B, Jonmundsson G, Hasle H. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001. Br J Haematol. 2005; 131: 50–58
   PubMed Web of Science ®Google Scholar
• Slats AM, Egeler RM, Van Der Does-van den Berg A, et al. Causes of death—other than progressive leukemia—in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia. 2005; 19: 537–544
   PubMed Web of Science ®Google Scholar
• Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia. 2000; 14: 2205–2222
   PubMed Web of Science ®Google Scholar
• Hargrave DR, Hann, II, Richards SM, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol. 2001; 112: 293–299
   PubMed Web of Science ®Google Scholar
• Conter V, Arico M, Valsecchi MG, et al. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Haematologica. 1998; 83: 791–799
   PubMed Web of Science ®Google Scholar
• Lannigan R, Austin TW, Vestrup J. Myositis and rhabdomyolysis due to Staphylococcus aureus septicemia. J Infect Dis. 1984; 150: 784
   Google Scholar
• Kaiser AB, Rieves D, Price AH, et al. Tularemia and rhabdomyolysis. JAMA. 1985; 253: 241–243
   PubMed Web of Science ®Google Scholar
• Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1): a mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983; 308: 553–558
   PubMed Web of Science ®Google Scholar
• Clowes GH, Jr, George BC, Villee CA Jr, Saravis CA. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med. 1983; 308: 545–552
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Fujii Y, Tao S. An autopsy case of rhabdomyolysis associated with staphylococcal septicemia. Nippon Naika Gakkai Zasshi. 1988; 77: 1278–1279
   Google Scholar
• Rheingold OJ, Greenwald RA, Hayes PJ, Tedesco FJ. Myoglobinuria and renal failure associated with typhoid fever. JAMA. 1977; 238: 341
   Google Scholar
• Margolis D, Ross E, Miller KB. Rhabdomyolysis associated with high-dose cytarabine. Cancer Treat Rep. 1987; 71: 1325–1326
   Google Scholar
• Pugliese P, Danova M, Brugnatelli S, Piccolo G, Riccardi A, Ascari E. Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer. Haematologica. 2000; 85: 672
   Google Scholar
• Tabata N, Tanaka R, Suga S, et al. Rhabdomyolysis following administration of cyclophosphamide: a case report in a BMT recipient. Bone Marrow Transplant. 1996; 17: 1167–1169
   Google Scholar
• Koeffler HP, Haskell CM. Rhabdomyolysis as a complication of 5-azacytidine. Cancer Treat Rep. 1978; 62: 573–574
   Google Scholar
• Papakonstantinou C, Papanastasiou K, Kotsopoulou M, et al. Chemotherapy-related acute rhabdomyolysis. J Natl Cancer Inst. 1992; 84: 536–537
   Google Scholar
• Levy RJ, Sparano JA, Khan G. Rhabdomyolysis: an unusual complication of cytotoxic chemotherapy. Med Oncol. 1995; 12: 219–222
   Google Scholar
• Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore). 1982; 61: 141–152
   PubMed Web of Science ®Google Scholar
• Rowland LP. Myoglobinuria. Can J Neurol Sci. 1984; 11: 1–13
   Google Scholar
• Brumback RA, Feeback DL, Leech RW. Rhabdomyolysis in childhood: a primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production. Pediatr Clin North Am. 1992; 39: 821–858
   Google Scholar
• Lestin M, Hergert M, Lestin HG, et al. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Clin Lab. 2002; 48: 211–221
   Google Scholar
• Feinfeld DA, Cheng JT, Beysolow TD, Briscoe AM. A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis. Clin Nephrol. 1992; 38: 193–195
   PubMed Web of Science ®Google Scholar